Dimitrios Pappas - Dissemin

All papers authored by Dimitrios Pappas

This paper was not found in any repository, but could be made available legally by the author.

2022 Dimitrios A. Pappas

, Christine Brittle

, Andrew Concoff

, Andrew J. Holman

, Dennis Takasugi

, Joel M. Kremer

Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey

Upload

Distributing this paper is prohibited by the publisher

2021 Joel M. Kremer

, George Reed

, Dimitrios A. Pappas

, Kevin Kane

, Vivi L. Feathers

, Michael E. Weinblatt

, Nancy Shadick

, Jeffrey Greenberg

, Leslie L. Harrold

Dr. Kremer et al reply

Upload

Anthony James Ocon

, George Reed, Dimitrios A. Pappas

, Jeffrey R. Curtis

, Joel M. Kremer

Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis

Upload

Joel M. Kremer

, Clifton O. Bingham

, Laura C. Cappelli

, Jeffrey D. Greenberg, Ann M. Madsen, Jamie Geier, Jose L. Rivas, Alina M. Onofrei, Christine J. Barr, Dimitrios A. Pappas

, Heather J. Litman, Kimberly J. Dandreo, Andrea B. Shapiro, Carol A. Connell, Arthur Kavanaugh

Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry

Upload

2020 Dimitrios A. Pappas

, Christine Brittle

, James E. Mossell, Johanna B. Withers

, Jeraldine Lim-Harashima

, Joel M. Kremer

Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study

Upload

Dimitrios A. Pappas

, Gregory St John, Carol J. Etzel, Stefano Fiore, Taylor Blachley, Toshio Kimura, Rajeshwari Punekar, Kelechi Emeanuru, Jeannie Choi, Susan Boklage, Joel M. Kremer

Response to ‘Correspondence on ‘Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study’’ by Zheng et al

Upload

Kevin L. Winthrop

, Gustavo Citera, David Gold, Dan Henrohn, Carol A. Connell, Andrea B. Shapiro, Harry Shi, Alina M. Onofrei, Dimitrios A. Pappas

, Hendrik Schulze-Koops

Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry

Upload

Dimitrios A. Pappas

, Ying Shan, Tamara Lesperance, Greg Kricorian, Elaine Karis, Sabrina Rebello, Winnie Hua, Neil A. Accortt, Scott Stryker

Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry

Upload

Dimitrios A. Pappas

, Heather J. Litman

, Tamara Lesperance, Greg Kricorian

, Elaine Karis

, Sabrina Rebello

, Winnie Hua

, Neil A. Accortt

, Scott Stryker

Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data

Upload

Dimitrios A. Pappas

, Gregory St John, Carol J. Etzel, Stefano Fiore, Taylor Blachley, Toshio Kimura, Rajeshwari Punekar, Kelechi Emeanuru, Jeannie Choi, Susan Boklage, Joel M. Kremer

Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study

Upload

2019 Yuanfang Guan

, Hongjiu Zhang, Daniel Quang, Ziyan Wang, Stephen C. J. Parker, Dimitrios A. Pappas

, Joel M. Kremer, Fan Zhu

Machine Learning to Predict Anti–Tumor Necrosis Factor Drug Responses of Rheumatoid Arthritis Patients by Integrating Clinical and Genetic Markers

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Dimitrios Pappas